Healthcare provider profile · identity verified

Ricardo Machado, MD

Internal Medicine · CHICAGO, IL · NPI 1700879434

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	652	220
Metformin Hcl	Metformin Hcl	543	169
Losartan Potassium	Losartan Potassium	495	162
Lisinopril	Lisinopril	426	137
Amlodipine Besylate	Amlodipine Besylate	421	143
Tamsulosin Hcl	Tamsulosin Hcl	292	102
Duloxetine Hcl	Duloxetine Hcl	258	102
Hydrochlorothiazide	Hydrochlorothiazide	251	86
Glipizide Er	Glipizide	249	77
Levothyroxine Sodium	Levothyroxine Sodium	225	71
Famotidine	Famotidine	219	84
Diclofenac Sodium	Diclofenac Sodium	212	90
Gabapentin	Gabapentin	195	71
Albuterol Sulfate Hfa	Albuterol Sulfate	182	60
Metoprolol Succinate	Metoprolol Succinate	167	59
Candesartan Cilexetil	Candesartan Cilexetil	164	57
Pantoprazole Sodium	Pantoprazole Sodium	151	56
Pravastatin Sodium	Pravastatin Sodium	142	53
Tramadol Hcl	Tramadol Hcl	135	36
Omeprazole	Omeprazole	132	46
Simvastatin	Simvastatin	130	41
Alendronate Sodium	Alendronate Sodium	129	50
Rosuvastatin Calcium	Rosuvastatin Calcium	126	49
Trazodone Hcl	Trazodone Hcl	123	49
Metformin Hcl Er	Metformin Hcl	121	35
Azelastine Hcl	Azelastine Hcl	109	70
Mirtazapine	Mirtazapine	105	41
Carvedilol	Carvedilol	95	34
Montelukast Sodium	Montelukast Sodium	93	35
Furosemide	Furosemide	89	35
Trulicity	Dulaglutide	89	23
Ibuprofen	Ibuprofen	83	30
Meclizine Hcl	Meclizine Hcl	75	28
Jardiance	Empagliflozin	74	28
Alprazolam	Alprazolam	73	18
Fenofibrate	Fenofibrate	73	30
Clopidogrel	Clopidogrel Bisulfate	72	22
Finasteride	Finasteride	69	25
Pioglitazone Hcl	Pioglitazone Hcl	69	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	68	12
Lorazepam	Lorazepam	68	suppressed
Ammonium Lactate	Ammonium Lactate	66	30
Donepezil Hcl	Donepezil Hcl	66	28
Spironolactone	Spironolactone	65	22
Triamcinolone Acetonide	Triamcinolone Acetonide	64	29
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	61	18
Ezetimibe	Ezetimibe	59	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	58	22
Fluticasone Propionate	Fluticasone Propionate	57	25
Tradjenta	Linagliptin	57	21
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	57	14
Allopurinol	Allopurinol	56	20
Sildenafil Citrate	Sildenafil Citrate	56	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	19
Warfarin Sodium	Warfarin Sodium	55	12
Glipizide	Glipizide	53	22
Eliquis	Apixaban	50	17
Tizanidine Hcl	Tizanidine Hcl	50	32
Escitalopram Oxalate	Escitalopram Oxalate	48	29
Metoprolol Tartrate	Metoprolol Tartrate	47	19
Incruse Ellipta	Umeclidinium Bromide	46	suppressed
Januvia	Sitagliptin Phosphate	46	13
Lovastatin	Lovastatin	43	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	41	22
Alcohol Prep Pads	Alcohol Antiseptic Pads	38	14
Hydroxyzine Hcl	Hydroxyzine Hcl	38	12
Acetaminophen-Codeine	Acetaminophen With Codeine	35	suppressed
Chlorthalidone	Chlorthalidone	35	12
Combivent Respimat	Ipratropium/Albuterol Sulfate	35	suppressed
Ketoconazole	Ketoconazole	35	19
Memantine Hcl	Memantine Hcl	35	14
Sertraline Hcl	Sertraline Hcl	35	17
Zolpidem Tartrate	Zolpidem Tartrate	35	12
Sucralfate	Sucralfate	34	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	27
Ozempic	Semaglutide	32	suppressed
Myrbetriq	Mirabegron	31	suppressed
Prednisone	Prednisone	31	16
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	30	15
Mupirocin	Mupirocin	26	21
Atenolol	Atenolol	25	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	25	suppressed
Rybelsus	Semaglutide	25	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	24	suppressed
Atrovent Hfa	Ipratropium Bromide	24	suppressed
Clonazepam	Clonazepam	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	11
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	23	suppressed
Novolog Flexpen	Insulin Aspart	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Glimepiride	Glimepiride	21	suppressed
Baclofen	Baclofen	20	suppressed
Cephalexin	Cephalexin	20	17
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Solifenacin Succinate	Solifenacin Succinate	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Potassium Chloride	Potassium Chloride	19	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Azithromycin	Azithromycin	18	17
Doxepin Hcl	Doxepin Hcl	18	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	18	suppressed
Megestrol Acetate	Megestrol Acetate	18	suppressed
Nitroglycerin	Nitroglycerin	18	11
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	17
Cilostazol	Cilostazol	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Linzess	Linaclotide	16	suppressed
Loperamide	Loperamide Hcl	16	suppressed
Vascepa	Icosapent Ethyl	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Colchicine	Colchicine	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Scopolamine	Scopolamine	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Naproxen	Naproxen	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Testosterone	Testosterone	11	suppressed
True Comfort Safety Pen Needle	Pen Needle, Diabetic, Safety	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error